62
Participants
Start Date
September 11, 2023
Primary Completion Date
January 30, 2025
Study Completion Date
February 13, 2025
CVN424 150 mg
Participants will receive 1 CVN424 tablet (150 mg) per day.
Placebo
Participants will receive 1 matching placebo tablet per day.
Weill Cornell Medicine, New York
Icahn School of Medicine at Mount Sinai, New York
Parkinson's Research Centers of America - Long Island, Commack
Albany Medical Center, Albany
Inova Neurology - Fairfax, Fairfax
Inova Fairfax Medical Campus, Falls Church
Duke University Medical Center, Durham
Augusta University, Augusta
N1 Research LLC, Orlando
Parkinson's Disease and Movement Disorders Center of Boca Raton, Boca Raton
SFM Clinical Research, LLC, Boca Raton
University of South Florida Parkinson's Disease and Movement Disorders Center, Tampa
Parkinson's Disease Treatment Center of SWFL, Port Charlotte
University of Alabama at Birmingham, Birmingham
Veracity Neuroscience, Memphis
University of Kentucky, Center for Clinical and Translational Sciences, Lexington
The Ohio State University Department of Neurology - Madden Center for Parkinson Disease and Other Movement Disorders, Columbus
The Ohio State University Wexner Medical Center, Columbus
Martha Morehouse Medical Plaza, Columbus
Riverhills Healthcare, Inc dba Riverhills Neuroscience, Cincinnati
University of Michigan Department of Neurology, Ann Arbor
Quest Research Institute, Farmington Hills
Froedtert Hospital Department of Neurology, Milwaukee
Medical College of Wisconsin Department of Neurology, Milwaukee
Struthers Parkinson's Center, Golden Valley
University of Kansas Medical Center, Kansas City
Gill Neuroscience, Houston
Horizon Clinical Research Group, Cypress
Texas Movement Disorder Specialists, PLLC, Georgetown
Central Texas Neurology Consultants, Round Rock
CenExel Rocky Mountain Clinical Research, Englewood
Barrow Neurological Institute, Phoenix
St Joseph's Hospital and Medical Center, Phoenix
Movement Disorders Center of Arizona, LLC, Scottsdale
Muhammad Ali Parkinson Center, Phoenix
Parkinson's Research Centers of America - Palo Alto, Palo Alto
Oregon Health & Science University, Portland
EvergreenHealth Neuroscience Institute, Kirkland
EvergreenHealth Research Department, Kirkland
University of Kentucky, Dept of Neurology Kentucky Neuroscience Institute Research, Lexington
Beth Israel Deaconess Medical Center, Boston
University of Michigan Hospital / Michigan Clinical Research Unit (MCRU) Cardiovascular Center, Ann Arbor
Cerevance Beta, Inc.
INDUSTRY